Masimo Corporation (NASDAQ:MASI) Short Interest Up 17.6% in April

Masimo Corporation (NASDAQ:MASI – Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 3,818,925 shares, a growth of 17.6% from the March 31st total of 3,248,048 shares. Based on an average daily trading volume, of 697,853 shares, the days-to-cover ratio is currently 5.5 days. Currently, 7.9% of the shares of the company are sold short.

Masimo Price Performance

NASDAQ:MASI traded up $0.05 during mid-day trading on Friday, reaching $178.48. 1,040,776 shares of the company were exchanged, compared to its average volume of 620,464. Masimo has a 12 month low of $125.94 and a 12 month high of $179.00. The company has a fifty day moving average of $177.21 and a 200 day moving average of $153.89. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. The stock has a market cap of $9.59 billion, a PE ratio of -16.93, a PEG ratio of 1.81 and a beta of 1.13.

Get Masimo alerts:

Institutional Investors Weigh In On Masimo

A number of hedge funds have recently added to or reduced their stakes in MASI. 180 Wealth Advisors LLC lifted its stake in shares of Masimo by 2.5% in the 1st quarter. 180 Wealth Advisors LLC now owns 2,728 shares of the medical equipment provider’s stock valued at $485,000 after purchasing an additional 66 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 66 shares during the period. Clearstead Advisors LLC lifted its stake in shares of Masimo by 18.4% in the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73 shares during the period. Hantz Financial Services Inc. lifted its stake in shares of Masimo by 12.9% in the 4th quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 75 shares during the period. Finally, Assetmark Inc. lifted its stake in shares of Masimo by 5.5% in the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after purchasing an additional 97 shares during the period. Institutional investors own 85.96% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on MASI. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a research note on Tuesday, February 17th. Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research note on Tuesday, February 17th. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Finally, Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Eight research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $181.17.

View Our Latest Stock Analysis on Masimo

Masimo Company Profile

(Get Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Recommended Stories

• Five stocks we like better than Masimo

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.